Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection
Ka Lip Chew, Shaun Shi Yan Tan, Sharon Saw, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 9, pp. 1256.e9-1256.e11
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Joseph E. Ebinger, Justyna Fert‐Bober, Ignat Printsev, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 981-984
Open Access | Times Cited: 578
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020)
Kimberly E. Hanson, Angela M. Caliendo, Cesar Andres Diaz Arias, et al.
Clinical Infectious Diseases (2020) Vol. 78, Iss. 7, pp. e150-e169
Open Access | Times Cited: 182
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 177
The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children
Itai Dattner, Yair Goldberg, Guy Katriel, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 2, pp. e1008559-e1008559
Open Access | Times Cited: 171
Post–COVID-19 chronic symptoms: a postinfectious entity?
Benjamin Davido, Sophie Seang, Roland Tubiana, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 11, pp. 1448-1449
Open Access | Times Cited: 157
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
Andrea Padoan, Francesco Bonfante, Matteo Pagliari, et al.
EBioMedicine (2020) Vol. 62, pp. 103101-103101
Open Access | Times Cited: 143
Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups
Madhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 7
Open Access | Times Cited: 116
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing
Mary K. Hayden, Ibrahim K El Mikati, Kimberly E. Hanson, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 62
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Mei San Tang, James Brett Case, Caroline E Franks, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 12, pp. 1538-1547
Open Access | Times Cited: 127
Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy
Astha Thakkar, Kith Pradhan, Shawn Jindal, et al.
Nature Cancer (2021) Vol. 2, Iss. 4, pp. 392-399
Open Access | Times Cited: 101
Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
Chao Wu, Abraham J. Qavi, Asmaa Hachim, et al.
iScience (2021) Vol. 24, Iss. 6, pp. 102681-102681
Open Access | Times Cited: 92
Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity
Sandy Joung, Joseph E. Ebinger, Nancy Sun, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2227241-e2227241
Open Access | Times Cited: 44
Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2
Raymond T. Suhandynata, Melissa Hoffman, Deli Huang, et al.
Clinical Chemistry (2020) Vol. 67, Iss. 2, pp. 404-414
Open Access | Times Cited: 67
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study
Paola Stefanelli, Antonino Bella, Giorgio Fedele, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 4, pp. 633.e1-633.e7
Open Access | Times Cited: 55
The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children
Itai Dattner, Yair Goldberg, Guy Katriel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 50
Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022
Anna Bratcher, Jefferson M. Jones, William A. Meyer, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313620-e0313620
Open Access
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays
Shaun Shi Yan Tan, Sharon Saw, Ka Lip Chew, et al.
Pathology (2020) Vol. 52, Iss. 7, pp. 770-777
Open Access | Times Cited: 39
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
Jackrapong Bruminhent, Chavachol Setthaudom, Rungthiwa Kitpermkiat, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
SARS‐CoV‐2‐Specific Antibodies in Pediatric Solid Organ Transplant Recipients: Benefits of Additional Vaccine Doses
Amanda L. Adler, Alpana Waghmare, Jodi M. Smith, et al.
Pediatric Transplantation (2025) Vol. 29, Iss. 2
Closed Access
Comparative Clinical Evaluation of the Roche Elecsys and Abbott Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology Assays for Coronavirus Disease 2019 (COVID-19)
Shaun Shi Yan Tan, Sharon Saw, Ka Lip Chew, et al.
Archives of Pathology & Laboratory Medicine (2020) Vol. 145, Iss. 1, pp. 32-38
Open Access | Times Cited: 38
Technical considerations to development of serological tests for SARS-CoV-2
Emilie Ernst, Patricia Wolfe, Corrine M. Stahura, et al.
Talanta (2020) Vol. 224, pp. 121883-121883
Open Access | Times Cited: 35
Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
Hadi M. Yassine, Hadeel Al-Jighefee, Duaa W. Al‐Sadeq, et al.
International Journal of Infectious Diseases (2020) Vol. 102, pp. 181-187
Open Access | Times Cited: 32
Post–COVID-19 Acute Disseminated Encephalomyelitis in a 17-Month-Old
Loren McLendon, Chethan K. Rao, Cintia Carla Da Hora, et al.
PEDIATRICS (2021) Vol. 147, Iss. 6
Closed Access | Times Cited: 31
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2
Laura Olbrich, Noemi Castelletti, Yannik Schälte, et al.
Journal of General Virology (2021) Vol. 102, Iss. 10
Open Access | Times Cited: 29
SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)
Jackrapong Bruminhent, Chavachol Setthaudom, Pongsathon Chaumdee, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 3, pp. 813-822
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top